Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01946100 · ClinicalTrials.gov registry record · NA
Treatment of Multifocal Lung Adenocarcinoma
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT01946100: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT01946100 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01946100, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
To gather preliminary safety and outcome data for the multimodality treatment of lung adenocarcinoma in the setting of multifocal BAC.
Primary Outcome
Overall survival compared to survival for Stage IV NSCLC on NCCTG trials
Interventions
- GENETIC Multifocal Lung Adenocarcinoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-11-06 |
| Est. Completion | 2025-05-29 |
| Phase | NA |
Why NCT01946100 stopped before completion
NCT01946100 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Multifocal Lung Adenocarcinoma is the first listed.
NCT01946100 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01946100 about?
NCT01946100 is a clinical study titled "Treatment of Multifocal Lung Adenocarcinoma". To gather preliminary safety and outcome data for the multimodality treatment of lung adenocarcinoma in the setting of multifocal BAC.
What is the current status of trial NCT01946100?
This trial is currently terminated. It is a NA study. The enrollment target is 100 participants. The study started on 2013-11-06. Estimated completion is 2025-05-29.
What interventions are being tested in trial NCT01946100?
The interventions under investigation include: Multifocal Lung Adenocarcinoma (GENETIC).
Who is sponsoring clinical trial NCT01946100?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01946100's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI